Research Groups

Section of Molecular Pathology

Recent Publications - 12 most recent publications

1. Anantharaman D., Abedi-Ardekani B., Beachler D. C., Gheit T., Olshan A. F., Wisniewski K., Wunsch-Filho V., Toporcov T. N., Tajara E. H., Levi J. E., Moyses R. A., Boccia S., Cadoni G., Rindi G., Ahrens W., Merletti F., Conway D. I., Wright S., Carreira C., Renard H., Chopard P., McKay-Chopin S., Scelo G., Tommasino M., Brennan P., D'Souza G. (2017) Geographic heterogeneity in the prevalence of human papillomavirus in head and neck cancer Int J Cancer; 140(9):1968-1975. PMID: 28108990

2. Wang Q., Satomi K., Oh J. E., Hutter B., Brors B., Diessl N., Liu H. K., Wolf S., Wiestler O., Kleihues P., Koelsch B., Kindler-Rohrborn A., Ohgaki H. (2016) Braf Mutations Initiate the Development of Rat Gliomas Induced by Postnatal Exposure to N-Ethyl-N-Nitrosourea Am J Pathol; 186(10):2569-76. PMID: 27658714

3. Zhao F., Ohgaki H., Xu L., Giangaspero F., Li C., Li P., Yang Z., Wang B., Wang X., Wang Z., Ai L., Zhang J., Luo L., Liu P. (2016) Molecular subgroups of adult medulloblastoma: a long-term single-institution study Neuro Oncol; 18(7):982-90. PMID: 27106407

4. Oh J. E., Ohta T., Nonoguchi N., Satomi K., Capper D., Pierscianek D., Sure U., Vital A., Paulus W., Mittelbronn M., Antonelli M., Kleihues P., Giangaspero F., Ohgaki H. (2016) Genetic Alterations in Gliosarcoma and Giant Cell Glioblastoma Brain Pathol; 26(4):517-22. PMID: 26443480

5. Gramatzki D., Dehler S., Rushing E. J., Zaugg K., Hofer S., Yonekawa Y., Bertalanffy H., Valavanis A., Korol D., Rohrmann S., Pless M., Oberle J., Roth P., Ohgaki H., Weller M. (2016) Glioblastoma in the Canton of Zurich, Switzerland revisited: 2005 to 2009 Cancer; 122(14):2206-15. PMID: 27088883

6. Louis D. N., Perry A., Reifenberger G., von Deimling A., Figarella-Branger D., Cavenee W. K., Ohgaki H., Wiestler O. D., Kleihues P., Ellison D. W. (2016) The 2016 World Health Organization Classification of Tumors of the Central Nervous System: a summary Acta Neuropathol; 131(6):803-20. PMID: 27157931

7. Stewart B. W., Bray F., Forman D., Ohgaki H., Straif K., Ullrich A., Wild C. P. (2016) Cancer prevention as part of precision medicine: 'plenty to be done' Carcinogenesis; 37(1):2-9. PMID: 26590901

8. Walsh K. M., Ohgaki H., Wrensch M. R. (2016) Epidemiology Handb Clin Neurol; 3-18. PMID: 26948345

9. Parroche P., Roblot G., Le Calvez-Kelm F., Tout I., Marotel M., Malfroy M., Durand G., McKay J., Ainouze M., Carreira C., Allatif O., Traverse-Glehen A., Mendiola M., Pozo-Kreilinger J. J., Caux C., Tommasino M., Goutagny N., Hasan U. A. (2016) TLR9 re-expression in cancer cells extends the S-phase and stabilizes p16(INK4a) protein expression Oncogenesis; 5(7):e244. PMID: 27454079

10. Oh J.E., Ohta T., Satomi K., Foll M., Durand G., McKay J., Le Calvez-Kelm F., Mittelbronn M., Brokinkel B., Paulus W., Ohgaki H. (2015) Alterations in the NF2/LATS1/LATS2/YAP Pathway in Schwannomas J Neuropathol. Exp. Neurol; 74(10):952-959. PMID: 26360373

11. Xu Q.F., Pan Y.W., Li L.C., Zhou Z., Huang Q.L., Pang J.C., Zhu X.P., Ren Y., Yang H., Ohgaki H., Lv S.Q. (2014) MiR-22 is Frequently Downregulated in Medulloblastomas and Inhibits Cell Proliferation via the Novel Target PAPST1 Brain Pathol; 24(6):568-583. PMID: 24576181

12. Suzuki A., Nobusawa S., Natsume A., Suzuki H., Kim Y.H., Yokoo H., Nagaishi M., Ikota H., Nakazawa T., Wakabayashi T., Ohgaki H., Nakazato Y. (2014) Olig2 labeling index is correlated with histological and molecular classifications in low-grade diffuse gliomas J Neurooncol; 120(2):283-291. PMID: 25085214